chr14-50312145-C-A

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_024884.3(L2HGDH):​c.6G>T​(p.Val2Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00526 in 1,610,192 control chromosomes in the GnomAD database, including 32 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0030 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0055 ( 32 hom. )

Consequence

L2HGDH
NM_024884.3 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -0.256
Variant links:
Genes affected
L2HGDH (HGNC:20499): (L-2-hydroxyglutarate dehydrogenase) This gene encodes L-2-hydroxyglutarate dehydrogenase, a FAD-dependent enzyme that oxidizes L-2-hydroxyglutarate to alpha-ketoglutarate in a variety of mammalian tissues. Mutations in this gene cause L-2-hydroxyglutaric aciduria, a rare autosomal recessive neurometabolic disorder resulting in moderate to severe cognitive disability. [provided by RefSeq, Jul 2008]
DMAC2L (HGNC:18799): (distal membrane arm assembly component 2 like) This gene encodes a subunit of mitochondrial ATP synthase. Mitochondrial ATP synthase catalyzes ATP synthesis, utilizing an electrochemical gradient of protons across the inner membrane during oxidative phosphorylation. ATP synthase is composed of two linked multi-subunit complexes: the soluble catalytic core, F1, and the membrane-spanning component, Fo, comprising the proton channel. This gene encodes the subunit s, also known as factor B, of the proton channel. This subunit is necessary for the energy transduction activity of the ATP synthase complexes. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.62).
BP6
Variant 14-50312145-C-A is Benign according to our data. Variant chr14-50312145-C-A is described in ClinVar as [Likely_benign]. Clinvar id is 211349.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.256 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00304 (463/152338) while in subpopulation NFE AF = 0.00554 (377/68026). AF 95% confidence interval is 0.00508. There are 0 homozygotes in GnomAd4. There are 208 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position FAILED quality control check.
BS2
High Homozygotes in GnomAdExome4 at 32 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
L2HGDHNM_024884.3 linkc.6G>T p.Val2Val synonymous_variant Exon 1 of 10 ENST00000267436.9 NP_079160.1 Q9H9P8-1
DMAC2LNM_001382507.1 linkc.-286C>A upstream_gene_variant ENST00000557421.7 NP_001369436.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
L2HGDHENST00000267436.9 linkc.6G>T p.Val2Val synonymous_variant Exon 1 of 10 1 NM_024884.3 ENSP00000267436.4 Q9H9P8-1
DMAC2LENST00000557421.7 linkc.-286C>A upstream_gene_variant 5 NM_001382507.1 ENSP00000506374.1 A0A5K1VW60

Frequencies

GnomAD3 genomes
AF:
0.00304
AC:
463
AN:
152220
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00109
Gnomad AMI
AF:
0.00329
Gnomad AMR
AF:
0.00131
Gnomad ASJ
AF:
0.00202
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.000753
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00554
Gnomad OTH
AF:
0.000955
GnomAD2 exomes
AF:
0.00274
AC:
659
AN:
240246
AF XY:
0.00268
show subpopulations
Gnomad AFR exome
AF:
0.00132
Gnomad AMR exome
AF:
0.000938
Gnomad ASJ exome
AF:
0.00152
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000846
Gnomad NFE exome
AF:
0.00506
Gnomad OTH exome
AF:
0.00338
GnomAD4 exome
AF:
0.00550
AC:
8012
AN:
1457854
Hom.:
32
Cov.:
33
AF XY:
0.00530
AC XY:
3843
AN XY:
725260
show subpopulations
Gnomad4 AFR exome
AF:
0.000897
AC:
30
AN:
33430
Gnomad4 AMR exome
AF:
0.000921
AC:
41
AN:
44526
Gnomad4 ASJ exome
AF:
0.00111
AC:
29
AN:
26070
Gnomad4 EAS exome
AF:
0.0000505
AC:
2
AN:
39632
Gnomad4 SAS exome
AF:
0.000267
AC:
23
AN:
85982
Gnomad4 FIN exome
AF:
0.000805
AC:
41
AN:
50952
Gnomad4 NFE exome
AF:
0.00688
AC:
7645
AN:
1111228
Gnomad4 Remaining exome
AF:
0.00333
AC:
201
AN:
60280
Heterozygous variant carriers
0
476
952
1429
1905
2381
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
310
620
930
1240
1550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00304
AC:
463
AN:
152338
Hom.:
0
Cov.:
33
AF XY:
0.00279
AC XY:
208
AN XY:
74492
show subpopulations
Gnomad4 AFR
AF:
0.00108
AC:
0.00108246
AN:
0.00108246
Gnomad4 AMR
AF:
0.00131
AC:
0.00130668
AN:
0.00130668
Gnomad4 ASJ
AF:
0.00202
AC:
0.00201613
AN:
0.00201613
Gnomad4 EAS
AF:
0.00
AC:
0
AN:
0
Gnomad4 SAS
AF:
0.000207
AC:
0.000206868
AN:
0.000206868
Gnomad4 FIN
AF:
0.000753
AC:
0.000752729
AN:
0.000752729
Gnomad4 NFE
AF:
0.00554
AC:
0.005542
AN:
0.005542
Gnomad4 OTH
AF:
0.000945
AC:
0.00094518
AN:
0.00094518
Heterozygous variant carriers
0
25
50
75
100
125
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00469
Hom.:
1
Bravo
AF:
0.00320
Asia WGS
AF:
0.000866
AC:
3
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 26, 2016
Mayo Clinic Laboratories, Mayo Clinic
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

May 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

L2HGDH: BP4, BP7, BS2 -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:2
Oct 12, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 14, 2016
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

L-2-hydroxyglutaric aciduria Benign:2
Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 31, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.62
CADD
Benign
4.9
DANN
Benign
0.72
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs113626637; hg19: chr14-50778863; COSMIC: COSV108023877; COSMIC: COSV108023877; API